Medical Weight Loss

Semaglutide

Once-weekly injection
Can be self administered
Slows intestinal motility
GLP-1 (glucagon-like peptide receptor agonist)
Mimics a naturally occurring hormone in the body
Lowers blood sugars through reducing the production of sugar in the liver
Stimulates insulin secretion by the pancreas

Semaglutide

Once-weekly injection
Can be self-administered
GLP-1 receptor agonist and GIP (Gastric inhibitory polypeptide)
Delays stomach emptying leading to feeling of fullness and satisfaction with smaller portions
Communicates sensation of fullness in your brain
Reduces appetite
Slows intestinal motility
Lowers blood sugars through reducing the production of sugar in the liver
Stimulates insulin secretion by the pancreas

Tirezepatide contains an additional active hormone (GIP) compared to Semaglutide. Studies have sho

schedule appointment